FFRct vs Zio ECG Utilization Software (ZEUS) System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
HeartFlow FFRct is designed for the non-invasive diagnosis and treatment planning of coronary artery disease using CCTA scans and computational fluid dynamics. In contrast, the Zio ECG Utilization Software (ZEUS) System focuses on detecting and classifying cardiac arrhythmias through continuous analysis of wearable ECG data. While both leverage AI in cardiology, their distinct applications target different cardiac conditions and utilize different diagnostic data sources.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is designed for the non-invasive diagnosis of coronary artery disease (CAD) by assessing blood flow in coronary arteries. The Zio ECG Utilization Software (ZEUS) System is intended to aid physicians in the diagnosis and management of cardiac arrhythmias.
HeartFlow FFRct Analysis utilizes data from CCTA scans to create personalized 3D models of coronary arteries. The Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data collected from wearable Zio monitors.
FFRct Analysis is an AI-powered tool that uses computational fluid dynamics to generate 3D models and analyze blood flow, identifying areas of narrowing. The ZEUS System employs AI algorithms and proprietary deep-learned algorithms for arrhythmia detection and classification from continuous ECG data.
HeartFlow FFRct Analysis is primarily aimed at Cardiology and Radiology specialists. The Zio ECG Utilization Software (ZEUS) System is designed for use by Cardiology, Family Medicine, and Internal Medicine practitioners.
More Comparisons
Backers
Who funded each tool's parent company.